Franklyn J A, Sheppard M C, Ramsden D B
Eur J Clin Pharmacol. 1984;26(5):633-4. doi: 10.1007/BF00543499.
Total thyroxine and triiodothyronine levels are often reduced in long-term phenytoin therapy, a finding at variance with the euthyroid clinical state of these subjects. We have measured free (biologically active) thyroid hormone levels in 31 patients on phenytoin therapy and have found a significant reduction in measurements of both free thyroxine and free triiodothyronine. In contrast, addition of phenytoin to normal serum in vitro resulted in an increase in free thyroxine and free triiodothyronine concentrations. The findings in vitro are consistent with displacement of thyroid hormones from thyroxine binding globulin while the reduced free hormone levels in vivo confirm that the effects of phenytoin are not confined to binding inhibition and suggest that phenytoin has induced a change in the cellular metabolism of thyroid hormones.
长期使用苯妥英治疗时,总甲状腺素和三碘甲状腺原氨酸水平常降低,这一发现与这些患者的甲状腺功能正常的临床状态不符。我们检测了31例接受苯妥英治疗患者的游离(生物活性)甲状腺激素水平,发现游离甲状腺素和游离三碘甲状腺原氨酸的测量值均显著降低。相比之下,在体外向正常血清中加入苯妥英会导致游离甲状腺素和游离三碘甲状腺原氨酸浓度升高。体外研究结果与甲状腺激素从甲状腺素结合球蛋白上被置换的情况一致,而体内游离激素水平降低证实苯妥英的作用不仅限于结合抑制,提示苯妥英已引起甲状腺激素细胞代谢的改变。